Calpain-1 inhibitors for selective treatment of rheumatoid arthritis: what is the future?

Author： Miller David J   Adams Sarah E   Hallett Maurice B   Allemann Rudolf K  

Publisher： Future Science

ISSN： 1756-8927

Source： Future Medicinal Chemistry, Vol.5, Iss.17, 2013-11, pp. : 2057-2074

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cytokine inhibitors in the treatment of rheumatoid arthritis

By Gabay Cem  

Expert Opinion on Biological Therapy, Vol. 2, Iss. 2, 2002-02 ,pp. : 135-149

Informa Healthcare

Access to resources Recommend Favorite

Anakinra: an inhibitor of IL-1 for the treatment of rheumatoid arthritis

By Fleischmann Roy   Stern Richard   Iqbal Imran  

Expert Opinion on Biological Therapy, Vol. 4, Iss. 8, 2004-08 ,pp. : 1333-1344

Informa Healthcare

Access to resources Recommend Favorite

Adalimumab in the treatment of rheumatoid arthritis

By Voulgari Paraskevi V   Kaltsonoudis Evripidis   Papagoras Charalampos   Drosos Alexandros A  

Expert Opinion on Biological Therapy, Vol. 12, Iss. 12, 2012-12 ,pp. : 1679-1686

Informa Healthcare

Access to resources Recommend Favorite

Etanercept in the treatment of rheumatoid arthritis

By Hunt Laura   Emery Paul  

Expert Opinion on Biological Therapy, Vol. 13, Iss. 10, 2013-10 ,pp. : 1441-1450

Informa Healthcare

Access to resources Recommend Favorite

Infliximab for the treatment of early rheumatoid arthritis

By Geletka Robin C   St Clair E William  

Expert Opinion on Biological Therapy, Vol. 5, Iss. 3, 2005-03 ,pp. : 405-417

Informa Healthcare

Access to resources Recommend Favorite